Envirotune-CAR-T:一种对缺氧反应和增强谷氨酸的CAR-T细胞疗法,用于克服瘤微环境介导的抑制
Wenying Li1, Jiannan Chen2, Jiayi Li1
1Nanjing Normal University, Nanjing, Jiangsu, China.
Journal for immunotherapy of cancer
|October 13, 2025
概括
工程CAR-T细胞通过SLC38A2的低氧反应控制和代谢增强克服瘤微环境的挑战,提高对固体瘤的疗效.
科学领域:
- 免疫治疗是一种免疫疗法.
- 癌症生物学 癌症生物学
- 细胞的新陈代谢
背景情况:
- 化学抗原受体 (CAR) -T细胞疗法在血液癌症中表现有前途,但由于免疫抑制性瘤微环境 (TME),在固体瘤中扎.
- 在TME内部的缺氧和营养缺乏会损害CAR-T细胞的功能,限制它们的增殖,持久性和杀死能力.
- 为了解决这些与TME相关的局限性,制定了一项新的双重监管CAR-T战略.
研究的目的:
- 设计下一代CAR-T平台,具有针对TME所施加的代谢和转录约束的双重适应.
- 通过提高它们对缺氧和营养缺乏条件的弹性来提高固体瘤中CAR-T细胞的疗效.
主要方法:
- 具有低氧反应调节元件 (VEGF衍生) 的工程CAR-T细胞,用于在低氧条件下持续的CAR表达.
- 过度表达的谷氨胺转运体SLC38A2以促进谷氨胺吸收和营养不良环境中的代谢适应性.
- 评估了抗瘤活性,增殖,记忆表型,疲劳标记,代谢途径 (qPCR) 和细胞呼吸 (海马试验).
主要成果:
- 与传统的CAR-T细胞相比,在缺氧和营养压力下,改造的CAR-T细胞表现出优异的抗瘤活性.
- 在工程CAR-T细胞中观察到增强的增殖,更高比例的记忆T细胞和减少的疲劳标记.
- 定量PCR和海马测定显示了高调的谷氨胺代谢,糖解和氧化酸化,SLC38A2淘汰赛逆转了这些代谢改善.
结论:
- SLC38A2被确定为一种关键的代谢调节剂,对于提高CAR-T细胞抗瘤功效至关重要.
- 这种双重监管策略提供了一种有希望的方法,以提高CAR-T细胞疗法的耐用性和有效性,在具有挑战性的瘤微环境中.
- 这些发现突出了代谢增强和低氧反应控制在固体瘤中推进CAR-T细胞治疗的潜力.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
02:53Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:27Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K